Entry |
|
Name |
Neramexane mesylate (USAN) |
Formula |
C11H23N. CH4SO3
|
Exact mass |
265.1712
|
Mol weight |
265.4127
|
Structure |
|
Class |
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
|
Efficacy |
Antidepressant, Dementia therapeutic agent, NMDA receptor antagonist |
Comment |
Treatment of depression, Alzheimer's disease, and pain
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
D05145 Neramexane mesylate
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN2B (NMDAR2B)
D05145 Neramexane mesylate (USAN)
|
Other DBs |
|
KCF data |
ATOM 17
1 C1z C 8.5400 -14.4200
2 C1x C 8.5400 -15.8200
3 C1z C 9.7524 -16.5200
4 C1x C 10.9649 -15.8200
5 C1z C 10.9649 -14.4200
6 C1x C 9.7524 -13.7200
7 C1a C 8.7625 -17.5099
8 C1a C 10.7424 -17.5099
9 N1a N 12.1960 -13.7090
10 C1a C 7.3276 -13.7200
11 C1a C 7.3276 -15.1200
12 C1a C 12.1961 -15.1309
13 O1d O 17.3605 -14.8060
14 S4a S 17.3605 -16.2024
15 C1a C 15.9642 -16.2024
16 O1d O 18.7569 -16.2024
17 O1d O 17.3605 -17.5987
BOND 16
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 3 7 1
8 3 8 1
9 5 9 1
10 1 10 1
11 1 11 1
12 5 12 1
13 13 14 2
14 14 15 1
15 14 16 1
16 14 17 2
|